Your browser doesn't support javascript.
loading
Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate.
Liu, Ken; Chen, Jinbiao; Zhao, Yang; Boland, Jade; Ting, Ka Ka; Lockwood, Glen; McKenzie, Catriona; Kench, James; Vadas, Mathew A; Gamble, Jennifer R; McCaughan, Geoffrey W.
Affiliation
  • Liu K; AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Chen J; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Zhao Y; Centenary Institute, University of Sydney, Sydney, NSW, Australia.
  • Boland J; Centenary Institute, University of Sydney, Sydney, NSW, Australia.
  • Ting KK; Centenary Institute, University of Sydney, Sydney, NSW, Australia.
  • Lockwood G; Centenary Institute, University of Sydney, Sydney, NSW, Australia.
  • McKenzie C; Centenary Institute, University of Sydney, Sydney, NSW, Australia.
  • Kench J; Biogerontology Group, ANZAC Research Institute, Sydney, NSW, Australia.
  • Vadas MA; New South Wales Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Gamble JR; New South Wales Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • McCaughan GW; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Front Immunol ; 14: 1245708, 2023.
Article in En | MEDLINE | ID: mdl-37795103
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Liver Neoplasms Limits: Animals / Humans / Infant Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Liver Neoplasms Limits: Animals / Humans / Infant Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Australia